Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Long-term Safety Registry of Multiple Sclerosis Patients Who Have Participated in Cladribine Clinical Studies (PREMIERE)

NCT01013350 is registered in ClinicalTrials.gov with EMD Serono as lead sponsor.

NCT NCT01013350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01013350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Long-term Safety Registry of Multiple Sclerosis Patients Who Have Participated in Cladribine Clinical Studies (PREMIERE)
Lead sponsor
EMD Serono
Phase
Observational
Overall status
Completed
Start date
November 30, 2009
Completion date
October 25, 2018
Enrollment
1,161 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis